Amonafide L-malate is not a substrate for multidrug resistance proteins in secondary acute myeloid leukemia

被引：7

作者：

Burcu, M. ^{[1
]}

O'Loughlin, K. L. ^{[2
]}

Ford, L. A. ^{[3
]}

Baer, M. R. ^{[1
,2
]}

机构：

[1] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA

[2] Roswell Pk Canc Inst, Lab Flow Cytometry, Buffalo, NY 14263 USA

[3] Roswell Pk Canc Inst, Clin Res Serv, Buffalo, NY 14263 USA

来源：

LEUKEMIA | 2008年 / 22卷 / 11期

关键词：

D O I：

10.1038/leu.2008.87

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：2110 / 2115

页数：7

共 7 条

[1]

Allen SL, 2006, J CLIN ONCOL, V24, p357S

[2] Amonafide, a topoisomerase II inhibitor, is unaffected by P-glycoprotein-mediated efflux [J].

Chau, MyDoanh ;

Christensen, Jennifer L. ;

Ajami, Alfred M. ;

Capizzi, Robert L. .

LEUKEMIA RESEARCH, 2008, 32 (03) :465-473

[3]

Erba HP, 2007, J CLIN ONCOL, V25

[4] Targeting the multidrug resistance-1 transporter in AML: molecular regulation and therapeutic strategies [J].

Mahadevan, D ;

List, AF .

BLOOD, 2004, 104 (07) :1940-1951

[5] Cyclosporin A is a broad-spectrum multidrug. resistance modulator [J].

Qadir, M ;

O'Loughlin, KL ;

Fricke, SM ;

Williamson, NA ;

Greco, WR ;

Minderman, H ;

Baer, MR .

CLINICAL CANCER RESEARCH, 2005, 11 (06) :2320-2326

[6] ABC transporters and drug resistance in leukemia: was P-gp nothing but the first head of the Hydra? [J].

Steinbach, D. ;

Legrand, O. .

LEUKEMIA, 2007, 21 (06) :1172-1176

[7] Breast cancer resistance protein (BCRP/MXR/ABCG2) in acute myeloid leukemia: discordance between expression and function [J].

Suvannasankha, A ;

Minderman, H ;

O'Loughlin, KL ;

Nakanishi, T ;

Greco, WR ;

Ross, DD ;

Baer, MR .

LEUKEMIA, 2004, 18 (07) :1252-1257

← 1 →